Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
CVS Health Corporation is a healthcare plans business based in the US. CVS Health Corporation shares (CVS) are listed on the NYSE and all prices are listed in US Dollars. CVS Health Corporation employs 213,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$84.86|
|52-week range||$54.30 - $90.07|
|50-day moving average||$84.34|
|200-day moving average||$81.13|
|Wall St. target price||$96.11|
|Dividend yield||$2 (2.34%)|
|Earnings per share (TTM)||$5.46|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-0.76%|
|1 month (2021-08-24)||1.25%|
|3 months (2021-06-24)||1.30%|
|6 months (2021-03-24)||15.91%|
|1 year (2020-09-24)||49.64%|
|2 years (2019-09-24)||34.85%|
|3 years (2018-09-24)||7.77%|
|5 years (2016-09-23)||90.6|
Valuing CVS Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CVS Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, CVS Health Corporation shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CVS Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8387. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $17.6 billion.
The EBITDA is a measure of a CVS Health Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$277.3 billion|
|Operating margin TTM||4.73%|
|Gross profit TTM||$48.2 billion|
|Return on assets TTM||3.52%|
|Return on equity TTM||10.17%|
|Market capitalisation||$112.8 billion|
TTM: trailing 12 months
There are currently 15.3 million CVS Health Corporation shares held short by investors – that's known as CVS Health Corporation's "short interest". This figure is 4.9% down from 16.1 million last month.
There are a few different ways that this level of interest in shorting CVS Health Corporation shares can be evaluated.
CVS Health Corporation's "short interest ratio" (SIR) is the quantity of CVS Health Corporation shares currently shorted divided by the average quantity of CVS Health Corporation shares traded daily (recently around 5.9 million). CVS Health Corporation's SIR currently stands at 2.6. In other words for every 100,000 CVS Health Corporation shares traded daily on the market, roughly 2600 shares are currently held short.
However CVS Health Corporation's short interest can also be evaluated against the total number of CVS Health Corporation shares, or, against the total number of tradable CVS Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CVS Health Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CVS Health Corporation shares in existence, roughly 10 shares are currently held short) or 0.0116% of the tradable shares (for every 100,000 tradable CVS Health Corporation shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CVS Health Corporation.
Find out more about how you can short CVS Health Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health Corporation's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.92/100
Social score: 9.06/100
Governance score: 2.75/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health Corporation hasn't always managed to keep its nose clean.
|Total ESG score||18.73|
|Total ESG percentile||18.84|
|Level of controversy||3|
Dividend payout ratio: 26.95% of net profits
Recently CVS Health Corporation has paid out, on average, around 26.95% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health Corporation shareholders could enjoy a 2.34% return on their shares, in the form of dividend payments. In CVS Health Corporation's case, that would currently equate to about $2 per share.
While CVS Health Corporation's payout ratio might seem fairly standard, it's worth remembering that CVS Health Corporation may be investing much of the rest of its net profits in future growth.
CVS Health Corporation's most recent dividend payout was on 1 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 July 2021 (the "ex-dividend date").
CVS Health Corporation's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health Corporation shares which in turn could have impacted CVS Health Corporation's share price.
Over the last 12 months, CVS Health Corporation's shares have ranged in value from as little as $54.3048 up to $90.0683. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health Corporation's is 0.8193. This would suggest that CVS Health Corporation's shares are less volatile than average (for this exchange).
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.